Comprehensive Update in Management of Diabetes Mellitus

This program was recorded on January 20, 2023 and is valid through January 20, 2026.

Learning Objectives:

At the conclusion of this program, the participant will be able to:

1. Summarize recommendations from clinical practice guidelines regarding diabetes. 2. Discuss clinical evidence and place in thera- py for oral diabetes and GLP-1 agonist agents. 3. Discuss the growing evidence and role of SGLT2 inhibitors and DPP-4 inhibitors within diabetes and non-diabetes patients. 4. Analyze role of bariatric surgery in management of morbid obesity and diabetes. 5. Describe complications and medication-related changed post-bariatric surgery. 6. Evaluate and develop medication regimens post- bariatric surgery through case studies

ACCREDITATION

University Learning Systems is accredited by the Accreditation Council for Pharmacy Education as a Provider of continuing pharmacy education.

California Board of Registered Nursing Provider No. CEP 11409, for 5 contact hours (0.5 CEU).

CE Broker Tracking #: 50-11357

PRINCIPAL AUDIENCE

PHARMACISTS: University Learning Systems reports credit to CPE Monitor. This course provides 5 contact hours (0.5 CEU).

UAN 0741-0000-22-002-H01-P ACTIVITY: APPLICATION. No Partial credit is awarded. This course is course is valid until January 20, 2026 and may be taken for credit up to that time.

CANADIAN PHARMACISTS: Canadian Council on Continuing Education in Pharmacy (CCCEP) accepts courses accredited by the Accreditation Council for Pharmacy Education (ACPE).

NURSE PRACTITIONERS/NURSES: This course provides 5 contact hours (0.5 CEU) of pharmacotherapeutics / pharmacology requirements for American Nurses Credentialing Center (ANCC) Category 1 Continuing Education Hours. The same hours submitted to renew certification may be submitted to a State Board of Nursing for re-licensure. American Nurses Credentialing Center (ANCC) accepts formally approved continuing education sponsored by organizations accredited or approved by the Accreditation Council for Pharmacy Education (ACPE).

OTHER HEALTH PROFESSIONALS: Please contact your respective board.

PHYSICIANS: This course may be considered for AMA Category 2 credit only.

CANADIAN PHYSICIANS: This course may be considered for AMA Category 2 credit only which may be equivalent to MAINPRO-M2 credits. Please contact your respective board.

PHYSICIAN ASSISTANTS: This course may be considered for AMA Category 2 credit only.